Literature DB >> 14501202

Inhibition of phosphatase activity prolongs NMDA-induced modification of the postsynaptic density.

A Dosemeci1, L Vinade, C A Winters, T S Reese, J-H Tao-Cheng.   

Abstract

NMDA-induced modification of postsynaptic densities (PSDs) was studied by immunoelectron microscopy. Treatment of cultured hippocampal neurons with NMDA for 2 min promotes a 2.3 fold thickening of the PSD and a 4 fold increase in PSD-associated CaMKII immunolabel. These changes are reversed 5 min after the removal of NMDA and Ca2+ from the medium. In addition, following NMDA treatment, PSDs exhibit a 7.5 fold increase in labeling with an antibody specific to the (Thr286) phospho-form of CaMKII, indicating that CaMKII translocated to the PSD is phosphorylated. When the phosphatase inhibitors, calyculin A or okadaic acid, are included in the medium, the NMDA-induced thickening of the PSD as well as the increase in PSD-associated CaMKII immunolabeling are largely maintained (75% and 88% of the peak values respectively) at 5 min after removal of NMDA and Ca2+ from the medium. These results imply that NMDA receptors can mediate activity-induced changes in the PSD and that phosphatases of type 1 and/or 2A are involved in the reversal of these changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14501202     DOI: 10.1023/a:1025735410738

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  17 in total

1.  alphaCaMKII autophosphorylation levels differ depending on subcellular localization.

Authors:  Kurtis D Davies; Rachel M Alvestad; Steven J Coultrap; Michael D Browning
Journal:  Brain Res       Date:  2007-05-10       Impact factor: 3.252

2.  NMDA-induced accumulation of Shank at the postsynaptic density is mediated by CaMKII.

Authors:  Jung-Hwa Tao-Cheng; Yijung Yang; K Ulrich Bayer; Thomas S Reese; Ayse Dosemeci
Journal:  Biochem Biophys Res Commun       Date:  2014-06-19       Impact factor: 3.575

3.  Quantitative estimates of the cytoplasmic, PSD, and NMDAR-bound pools of CaMKII in dendritic spines.

Authors:  Bihua Feng; Sridhar Raghavachari; John Lisman
Journal:  Brain Res       Date:  2011-08-27       Impact factor: 3.252

4.  Effects of CaMKII inhibitor tatCN21 on activity-dependent redistribution of CaMKII in hippocampal neurons.

Authors:  J-H Tao-Cheng; Y Yang; K U Bayer; T S Reese; A Dosemeci
Journal:  Neuroscience       Date:  2013-04-11       Impact factor: 3.590

Review 5.  CaMKII: claiming center stage in postsynaptic function and organization.

Authors:  Johannes W Hell
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

6.  Composition of the synaptic PSD-95 complex.

Authors:  Ayse Dosemeci; Anthony J Makusky; Ewa Jankowska-Stephens; Xiaoyu Yang; Douglas J Slotta; Sanford P Markey
Journal:  Mol Cell Proteomics       Date:  2007-07-09       Impact factor: 5.911

7.  Homer is concentrated at the postsynaptic density and does not redistribute after acute synaptic stimulation.

Authors:  J-H Tao-Cheng; S Thein; Y Yang; T S Reese; P E Gallant
Journal:  Neuroscience       Date:  2014-02-12       Impact factor: 3.590

8.  Rapid turnover of spinules at synaptic terminals.

Authors:  J-H Tao-Cheng; A Dosemeci; P E Gallant; S Miller; J A Galbraith; C A Winters; R Azzam; T S Reese
Journal:  Neuroscience       Date:  2009-02-25       Impact factor: 3.590

9.  Bi-directional regulation of CaMKIIα phosphorylation at Thr286 by NMDA receptors in cultured cortical neurons.

Authors:  Xianju Zhou; Fei Zheng; Changjong Moon; Oliver M Schlüter; Hongbing Wang
Journal:  J Neurochem       Date:  2012-06-06       Impact factor: 5.372

10.  Regulation of Ca²⁺/calmodulin-dependent protein kinase II signaling within hippocampal glutamatergic postsynapses during flurazepam withdrawal.

Authors:  Damien E Earl; Paromita Das; William T Gunning; Elizabeth I Tietz
Journal:  Neural Plast       Date:  2012-07-05       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.